Objective-Endothelial cells (ECs) are a highly specialized cell type with marked diversity between different organs or vascular beds. Cardiac ECs are an important player in cardiac physiology and pathophysiology but are not sufficiently characterized yet. Thus, the aim of the present study was to analyze the cardiac EC transcriptome. Approach and Results-We applied fluorescence-assisted cell sorting to isolate pure ECs from adult mouse hearts. RNAseq revealed 1288 genes predominantly expressed in cardiac ECs versus heart tissue including several transcription factors. We found an overrepresentation of corresponding transcription factor binding motifs within the promotor region of EC-enriched genes, suggesting that they control the EC transcriptome. Cardiac ECs exhibit a distinct gene expression profile when compared with renal, cerebral, or pulmonary ECs. For example, we found the Meox2/Tcf15, Fabp4, and Cd36 signaling cascade higher expressed in cardiac ECs which is a key regulator of fatty acid uptake and involved in the development of atherosclerosis. Conclusions-The results from this study provide a comprehensive resource of gene expression and transcriptional control in cardiac ECs. The cardiac EC transcriptome exhibits distinct differences in gene expression compared with other cardiac cell types and ECs from other organs. We identified new candidate genes that have not been investigated in ECs yet as promising targets for future evaluation.
ndothelial cells (ECs) form the inner layer of blood and lymphatic vessels. They are involved in a variety of physiological processes including the control of vasomotor tone and blood flow, vascular permeability, leukocyte trafficking, and angiogenesis. 1 Between different and even within 1 organ, ECs show marked cellular diversity. 1, 2 This includes the specification into arterial, venous, capillary, or lymphatic ECs from different vascular beds and a large number of functionally specialized endothelium such as fenestrated glomerular endothelium or the ECs forming the blood-brain barrier. 2 In addition to their own function, ECs interact with different other cell types in an organ-specific manner. 3 In the heart, ECs are one of the most abundant cell types, 4, 5 and there is a growing body of evidence for their central role in cardiovascular disease. There is extensive EC to cardiomyocyte paracrine communication modulating hypertrophic growth. 6, 7 Vice versa, cardiomyocytes can promote angiogenic signaling in ECs and thereby vascularization of the heart and nutrition supply. 8 ECs interact with immune cells and fibroblasts to control cardiac inflammation and extracellular matrix composition. 6, 7 This ascribes them a particular role in the translation of cardiovascular risk factors into disease. 9 Different studies using RNAseq gene expression data of ECs from brain, 10 kidney, 11 aorta, 12 or peripheral vasculature 13 provide evidence that the endothelial transcriptome is both cell type and organ specific. This reflects the distinct physiological roles of ECs from different organs but might also explain their specific response to stimulus during disease. A recently launched database provides an overview of available data sets 14 ; however, a comparable resource for cardiac ECs is lacking. Thus, the aim of the present study was to describe and analyze the transcriptome of cardiac ECs as 1 integral cell type involved in cardiac disease.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Isolation of Cardiac ECs
To study the cardiac EC transcriptome, we created endothelial lineage reporter mice with cell type-specific expression of GFP (green fluorescent protein; Cdh5 (cadherin 5)-GFP; Figure 1A and 1B). Transgenic GFP expression in ECs did not alter cardiac morphology, function, or Cdh5 mRNA expression ( Figure I in the online-only Data Supplement).
After enzymatic and mechanical tissue dissection, 151 000±41 000 GFP-positive ECs per heart were obtained by fluorescence-assisted cell sorting (n=3; Figure 1C and 1D). To validate the purity of the EC fraction, we assessed the expression levels of cell type-specific marker genes ( Figure 1E through 1G) . Typical EC marker genes (Cdh5, Pecam1, Vwf, Tek, Kdr [vascular endothelial growth factor receptor type 2]) were enriched in purified ECs versus heart tissue, whereas we observed a depletion of markers for cardiac myocytes (Myh6, Pln, Atp2a2, Ryr2, Tnnt2), fibroblasts (Col1a1), macrophages (Lyz2, Emr1), or vascular smooth muscle cells (Myh11, Acta2; Figure 1E ).
We found 14 065 genes expressed (>1 fragments per kilobase of transcript per million fragments mapped) in heart tissue, isolated ECs, or both (Figure 2A) . Expression levels of all expressed genes showed little correlation between ECs and heart tissue ( Figure 2A ). However, correlation significantly increased for genes with higher expression in isolated ECs ( Figure 2B ). Expression of genes that are specifically expressed in 1 cell type is linearly correlated to their expression in the surrounding tissue. 15 Accordingly, heart tissue expression of EC-typical genes corresponded to their expression in isolated ECs. Genes with >2
3 -fold higher expression in ECs were considered to be typical for ECs (Spearman correlation coefficient R 2 =98.5 versus heart tissue; Figure 2B and 2D). Genes with >2-fold higher expression in ECs are termed EC enriched in this article ( Figure 2B through 2D). Reads from EC-enriched or EC-typical genes contributed to 15.5% of all mapped reads from heart tissue but 64.2% of reads from isolated ECs ( Figure 2C ). EC-typical genes are mostly classified as protein coding but contain also a proportion of 22 noncoding RNAs including Malat1 or Neat1 (Table  II in 
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Signaling Pathway Analysis
Expression of lineage marker genes displayed a typical EC pattern with low expression of mesodermal progenitor markers such as Mesp1 and high expression of VEGF receptor type 2 (Kdr), Cdh5, or Pecam1 ( Figure 3A ). Transcription factors promoting arterial (Foxc, Hey, Notch) or venous (Sox7, Nr2f2) EC specification were enriched, whereas transcription factors determining lymphatic specification (Prox1, Pdgfrb) were similarly expressed in ECs and heart tissue ( Figure 3A) . 16, 17 To describe the molecular function of EC-typical genes in more detail, we performed gene expression network analysis using ClueGO ( Figure 3B ; Figure II in the online-only Data Supplement). We found single signaling pathways or groups of signaling pathways from gene ontology or Kyoto Encyclopedia of Genes and Genomes database significantly (P<0.001) overrepresented among EC-typical genes, including typical pathways reflecting EC function such as blood vessel morphogenesis, vasculogenesis, EC development, or regulation of EC differentiation ( Figure 3B ). In addition, network analysis revealed an overrepresentation of small GTPase signaling including Rap1 or Ras signaling ( Figure 3B) .
Genes depleted in ECs belonged to gene ontology terms related to muscle cell development, muscle contraction, and oxidative or metabolic processes indicating that they derive predominantly from cardiac myocytes ( Figure II in the onlineonly Data Supplement).
Transcriptional Regulation of the EC Transcriptome
We aimed to identify transcription factors regulating EC transcription. Eighty-one (6.3%) of the EC-typical genes were classified as transcription factors (gene ontology term GO:0003700, transcription factor activity, sequence-specific DNA binding; Figure 4A and 4B). These included members of the ETS (E26 transformation-specific) transcription factor family, the KLF (Kruppel-like factor) family, or signal transducer and activator of transcription 3 (Stat3 ; Figure 4A through 4C;  Tables II and III in the online-only Data Supplement). To estimate their significance for EC gene expression, we analyzed the 1100 bp promotor region of EC-enriched genes for the presence of transcription factor binding motifs ( Figure 4D ). Among others we found a significant overrepresentation of the ETS transcription factor family, KLF family, and interferon regulatory factor family binding motif (q<0.001; Figure 4D ). A closer analysis of the binding motif density within the promotor region revealed an accumulation in close proximity to the transcription start site ( Figure 4D ). In line with this, reanalysis of published transcriptome data revealed that the deletion of the EC-enriched transcription factors stem cell leukemia protein (Tal1 [T-cell acute lymphocytic leukemia protein 1]), 18 Klf2, 19 or Klf4 
Comparing the Cardiac to Other Organ EC Transcriptomes
To identify characteristics of ECs from different tissues, we isolated ECs from brain, kidney, lung, and skeletal muscle ( Figure 5A through 5D ) and compared their gene expression to cardiac ECs ( Figure 5E and 5F). Spearman correlation ( Figure 5E ) and principal component analysis proofed clustering of the replicates from 1 organ ( Figure 5F ).
We found 1126 genes differentially regulated in cardiac versus cerebral ECs, 1058 genes in cardiac versus renal ECs, and 738 genes in cardiac versus pulmonary ECs (q<0.05; Figure 6A through 6C) including several genes with known biological function in ECs. For example, we found vascular cellular adhesion molecule 1 (Vcam1) enriched in cardiac Genes >2 1 -fold or >2 3 -fold (q<0.05) higher expressed in ECs vs heart tissue were considered to be EC enriched (light green dotted line) or EC typical (dark green dotted line, B), respectively. Read count (% FPKM) from EC-enriched (light and dark green) or EC-typical (dark green) genes was analyzed in RNAseq data from heart tissue or isolated ECs (C). Gene expression in isolated ECs or heart tissue clustered into 5 groups (D). Heart, n=4, ECs, n=3.
versus renal and pulmonary ECs or G-protein-coupled receptor 124 (Gpr124) enriched in brain versus cardiac ECs (Table  IV in the online-only Data Supplement).
We analyzed the overlap of genes enriched in cardiac ECs and considered 143 genes that were concordantly upregulated versus other organs as typical for cardiac ECs ( Figure 6D ). Gene network analysis of typical cardiac EC genes revealed an enrichment (P<0.05) of genes related to cytokine-cytokine receptor interaction, extracellular matrix-receptor interaction, PPAR (peroxisome proliferator-activated receptor) signaling, and others ( Figure 6E) . Members of the PPAR signaling pathway such as the fatty acid transporter CD36 or fatty acid binding protein 4 (Fabp4) were among the genes with highest expression in cardiac ECs ( Figure 6F ) and gained our particular interest. mRNA expression of upstream regulatory factors of Cd36 and Fabp4 expression, transcription factor 15 (Tcf15; q<0.05; Figure 6F and 6G), and mesenchyme homeobox 2 (Meox2; q=0.07 versus pulmonary, q<0.05 versus cerebral or renal ECs, Table IV in the online-only Data Supplement), was enriched in cardiac versus other organ ECs. Expression of Cd36, Fabp4, Tcf15, and Meox2 was validated by quantitative reverse transcriptase PCR ( Figure 6H through 6K) .
To evaluate whether these differences were particular for ECs from heart versus other muscular tissue, we isolated ECs from hindlimb skeletal muscle ( Figure 5D ; Figure IVA in the online-only Data Supplement). Gene expression in skeletal muscle ECs showed high correlation (Spearman correlation coefficient R 2 =0.92-0.93; Figure 5E ) and clustering with cardiac ECs ( Figure 5F ). Expression of Cd36, Fabp4, Tcf15, and Meox2 was not different between cardiac and skeletal muscle ECs (Table V in 
Discussion
ECs play an important role in cardiac physiology and disease. We provide here a comprehensive data set and in-depth analysis of the cardiac EC transcriptome and compare it to the transcriptome of heart tissue and ECs from other organs.
Comparative analysis of EC versus heart tissue gene expression revealed 9.2% of expressed genes to be EC typical. This fits well with the results from previous studies in which the number of genes considered to be specific for 1 cell type varied from 10% to 34% depending on the tissue, cell isolation method, and cutoff applied. [20] [21] [22] Though ECs are highly abundant in the heart, 5 mapped reads from EC-enriched genes constitute only a minority of the heart tissue transcriptome. mRNA amount increases with cell size 23 and cardiac myocytes, the largest cell type of the heart, dominate the cardiac mRNA expression profile. Accordingly, genes depleted in ECs are related to muscle cell function and energy metabolism. This implies that changes in gene expression in smaller cell types might be masked, and it is required to perform specific analysis on isolated cells instead of tissue. However, cardiac ECs express both markers of arterial or venous specification 16 with higher expression of venous markers. Expression of these marker genes reflects the composition of the cardiac EC population and to assess gene expression in cardiac EC subtypes with low abundance, for example, valvular ECs might require additional sorting.
The differentiation of cardiac mesodermal progenitors into the different cell types of the heart and the specification of ECs is tightly regulated by transcription factors. 16, 17 The upregulation of the ETS transcription factor Etv2 plays a central role during differentiation of Mesp1-positive mesodermal progenitors toward myocyte 24 (Isl1 or Tbx-5 positive) or EC (Flk1 positive) fate. 16, 17 Importantly, Etv2 expression is restricted to a narrow time frame during differentiation 25 and is not detectable in mature ECs isolated from adult hearts. In contrast, other transcription factors that are involved in maintenance of cellular identity such as inhibitor of differentiation (Id1) 26 or stem cell leukemia protein (Tal1) 18, 27 are continuously expressed. In line with this, deletion of Tal1 leads to dysregulation of EC-expressed genes. We identified several transcription factors expressed that are typical for ECs within the heart. Transcription factor activity requires a corresponding binding site in the regulatory region of its target gene. Binding motifs of endothelial typical transcription factor families were overrepresented in the promotor region of EC-enriched genes. Some of these transcription factors have been described as key regulators of EC function, 16, 25 including the ETS transcription factor family or the KLF family. Deletion of either Klf2 or Klf4 in mice alters gene expression in cardiac ECs. 19 However, this effect is markedly aggravated in mice lacking both Klf2 and Klf4, leading to a severe dysregulation of EC gene expression, loss of EC function, and death. 19 Other transcription factors, such as myeloid nuclear differentiation antigen like (Mndal) or PAX binding protein (Gcfc1 [GC-rich sequence DNA-binding factor candidate]), are enriched but of unknown function in ECs. Access of a transcription factor to its corresponding binding site is regulated by coregulatory transcription factors and epigenetic modifications including chromatin state or DNA methylation. The results from the present study provide a basis for future studies on EC epigenetics.
The cardiac EC transcriptome shows marked differences when compared with ECs from other organs. These differences reflect the specialized function of ECs in different organs. In a previous study, we had identified Vcam1 to play an important role in mineralocorticoid-induced cardiac but not renal remodeling. 28 We show here that this is related to a 4-fold higher expression of Vcam1 in cardiac versus renal ECs. Vice versa, Gpr124, a G-protein-coupled receptor, is expressed in cerebral but not cardiac ECs and crucial for the maintenance of the blood-brain barrier as recently shown. Heart contraction and ion homeostasis are highly energy consuming and up to 90% of cardiac ATP derives from mitochondrial fatty acid oxidation. 30 Cardiac ECs in contrast to other organs need to provide continuous fatty acid supply for muscle contraction. When comparing cardiac versus renal, cerebral, or pulmonary ECs, we found genes upregulated that are linked to PPAR signaling, including Fabp4 and Cd36. Both FABP4 and CD36 facilitate fatty acid uptake from the circulation via the endothelial barrier. [31] [32] [33] This finding confirms a report comparing the microarray-based gene expression profile of cardiac versus brain or liver ECs. 32 In contrast, the transcriptome of ECs from heart and skeletal muscle showed high similarity, including comparable expression of Fabp4 and CD36, suggesting that ECs have similar functions in different muscular tissues.
We found the transcription factors TCF15 and MEOX2 enriched in cardiac ECs versus other tissues. TCF15 and MEOX2 cooperatively regulate the expression of CD36 and Fabp4 and other genes involved in fatty acid uptake. 32 Heterozygous deletion of TCF15 and MEOX2 in mice impairs fatty acid uptake and left ventricular function. 32 However, CD36 also plays a role in the development of atherosclerosis, 34 and genetic variations in the MEOX2 gene have been associated with an increased risk of coronary artery disease in humans. 35 Comparison of data from genome-wide association studies on patients with cardiovascular disease with cell type-specific gene expression data might be a promising approach to identify new disease-associated genes.
In conclusion, the results from this study provide a comprehensive resource of gene expression and transcriptional control in cardiac ECs. The cardiac EC transcriptome exhibits distinct differences in gene expression compared with other cardiac cell types and ECs from other organs. We found several transcription factors that control endothelial gene expression including transcription factors with well-known function in physiology and pathophysiology. We also propose new candidate genes with high expression levels and enrichment in cardiac ECs that have not been investigated yet as promising targets for future evaluation.
